References
- Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-56.
- Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
- Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist 2007;12:569-76.
- Banks PM, Warnke RA. Primary effusion lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 179-80.
- Adiguzel C, Bozkurt SU, Kaygusuz I, Uzay A, Tecimer T, Bayik M. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. APMIS 2009;117:222-9.
- Tanaka S, Katano H, Tsukamoto K, Jin M, Oikawa S, Nishihara H, et al. HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 2001;51:293-300.
- Carbone A, Gloghini A. PEL and HHV8-unrelated effusion lymphomas: classification and diagnosis. Cancer 2008;114:225-7.
- Takao T, Kobayashi Y, Kuroda J, Omoto A, Nishimura T, Kamitsuji Y, et al. Rituximab is effective for human herpesvirus-8-negative primary effusion lymphoma with CD20 phenotype associated hepatitis C virus-related liver cirrhosis. Am J Hematol 2004;77:419-20.
- Matsumoto Y, Nomura K, Ueda K, Satoh K, Yasuda N, Taki T, et al. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 2005;46:415-9.
- Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol 1998;22:1528-37.
- Inoue S, Miyamoto T, Yoshino T, Yamadori I, Hagari Y, Yamamoto O. Primary effusion lymphoma with skin involvement. J Clin Pathol 2006;59:1221-2.
- Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2001;120:356-61.
- Terasaki Y, Okumura H, Saito K, Sato Y, Yoshino T, Ichinohasama R, et al. HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med 2008;47:2175-8.
Cited by
- Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma : Report of a Rare Case and Review of 54 Cases in the Literature vol.140, pp.2, 2012, https://doi.org/10.1309/ajcphz3cho4huwet
- Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: Report of 3 cases and review of the literature : HHV8-Negative Effusion Lymphoma vol.121, pp.11, 2012, https://doi.org/10.1002/cncy.21311
- Human herpesvirus-8-unrelated primary effusion lymphoma of the elderly not associated with an increased serum lactate dehydrogenase level: A benign sub-group of effusion lymphoma without chemotherapy vol.57, pp.7, 2012, https://doi.org/10.3109/10428194.2015.1088649
- Trends in Pleural Effusion Research : A Bibliometric Analysis From the Scopus Database vol.3, pp.None, 2016, https://doi.org/10.1177/2373997516646555
- 以胸腔积液为首发症状的四例非HIV相关原发性渗出性淋巴瘤患者临床特征分析 vol.37, pp.7, 2016, https://doi.org/10.3760/cma.j.issn.0253-2727.2016.07.016
- Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and vol.49, pp.1, 2017, https://doi.org/10.4143/crt.2016.076
- Case Report: A rare case of a vanishing unilateral effusion vol.9, pp.None, 2012, https://doi.org/10.12688/f1000research.24711.1
- Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis vol.4, pp.18, 2012, https://doi.org/10.1182/bloodadvances.2020002293